Zobrazeno 1 - 9
of 9
pro vyhledávání: '"G M, Kuklina"'
Autor:
E. I. Shmelev, G. M. Kuklina
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 20-24 (2013)
Tthe epidemiological situation of tuberculosis in Russia remains a challenge. High level of morbidity is conditioned by migration process and inadequate monitoring of new people coming from other regions and patients from the units of the Main Direct
Externí odkaz:
https://doaj.org/article/ac4984b8469b4851b0d139ff3c47957f
Publikováno v:
Russian Pulmonology. 30:361-364
Clinical observation of multi-cavity lung cancer in a patient with chronic recurrent laryngeal papillomatosis in a 23-year-old patient who underwent annual surgical treatment (papillomatous laser removal) is presented. Pulmonary cavities have been de
Autor:
G. M. Kuklina, I.V. Sivokozov, E.I. Shmelev, Central Scientific, Russian Federation Moscow, N.N. Makaryants
Publikováno v:
Doctor.Ru. 19:38-41
Objective: To describe the use of bronchial thermoplastics (BT) in a female patient with severe hormone-dependent bronchial asthma (BA). Key Points. Because of the history of unsuccessful use of the basic BA therapy and continuous inefficient use of
Autor:
G. M. Kuklina, E. I. Shmelev
Publikováno v:
PULMONOLOGIYA. :39-45
Publikováno v:
Problemy tuberkuleza i boleznei legkikh. (2)
The paper gives data on the prevalence of nonspecific lung disease in patients with pulmonary tuberculosis, the specific features of diagnosis and treatment of their concomitance in 3453 patients with pulmonary tuberculosis. It shows the low detectio
Publikováno v:
Problemy tuberkuleza i boleznei legkikh. (8)
Whether the main points of treatment for bronchial obstructive syndrome (BOS) in chronic obstructive lung disease (COLD) can be adapted for patients with pulmonary tuberculosis (PT) was studied. For this purpose, 435 patients with PT with signs of BO
Autor:
E I, Shmelev, G M, Kuklina
Publikováno v:
Problemy tuberkuleza. (8)
Autor:
E I, Shmelev, G M, Kuklina
Publikováno v:
Problemy tuberkuleza. (7)
The efficiency of bronchodilating therapy described in the Federal Program for patients with chronic obstructive pulmonary diseases was evaluated in patients with lung tuberculosis with bronchial obstruction, treated in accordance with the Federal Pr
Publikováno v:
Problemy tuberkuleza. (3)
The levels of the antigen mucin 3EG5, a marker of the activity of interstitial lung diseases, were studied in the sera and bronchoalveolar swabs of patients with active tuberculosis, sarcoidosis of the respiratory organs, and idiopathic and exogenous